immune-support
Uncaria tomentosa (Willd. ex Schult.) DC.
The Hooked Vine Rebuilder
Crystalis is a reference resource for herbal, crystal, and somatic practice.
This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.
Botanical / meta
Thorned woody vine in the coffee family, worked from bark and root. Uncaria tomentosa climbs by curved hook-like thorns that give the plant its name, and the medicinal material comes from the inner bark rather than from leaf or flower. It is a forest liana medicine with both immune and inflammatory traditions.
Cat's Claw contains two pharmacologically distinct alkaloid classes: Pentacyclic Oxindole Alkaloids (POA, mitraphylline, isomitraphylline, pteropodine, isopteropodine, speciophylline, uncarine F) which are IMMUNOSTIMULATORY and therapeutically desired, and Tetracyclic Oxindole Alkaloids (TOA, rhynchophylline, isorhynchophylline) which have DIFFERENT and potentially ANTAGONISTIC effects, counteracting POA immunostimulatory activity. Additional compounds include quinovic acid glycosides (anti-inflammatory, antiviral), proanthocyanidins (antioxidant), catechins, triterpenes (ursolic acid, oleanolic acid), and beta-sitosterol. THE POA/TOA DISTINCTION IS CRITICAL: plant chemotype, harvesting season, geographic location, and time of day affect the ratio. TOA-dominant preparations may be therapeutically inert or counterproductive. The PRIMARY mechanism involves POA immunomodulation, enhancing B and T lymphocyte proliferation, increasing phagocytic activity, and modulating cytokine production. This is IMMUNOMODULATORY, not simply immunostimulatory, POA can upregulate suppressed immunity AND calm overactive immunity. Both POA and quinovic acid glycosides inhibit NF-kB activation, reducing TNF-alpha, IL-1beta, and IL-6. POA (specifically isopteropodine) enhances DNA repair mechanisms, potentially protecting against mutagenesis. TOA ANTAGONISM is the key quality concern: a preparation with high TOA/POA ratio will have reduced immune benefit.
Cat's claw supports immune resilience because alkaloids and polyphenols share the lane instead of competing for it. Pentacyclic oxindole alkaloids shape the classic immune story, while the bark matrix broadens the herb into inflammatory and gut-barrier conversations. It is better suited to long-pattern immune burden than to quick symptom suppression.
The Hooked Vine Rebuilder
Cat's claw is usually reached for when inflammation, immune complexity, or long-view tissue stress need a stronger jungle-vine corrective. It belongs first to the bark-and-vine support lane.
The practical read
Cat's claw sounds dramatic before the page has done any work, which means the writing should stay sober. This is a vine with hooked thorns and a long immune-inflammatory reputation, but public authority improves when the page keeps it on the ground: bark, extract, long-view modulation, and caution around interactions. Cat's claw belongs where a person needs more than a kitchen herb but less than a miracle. It should sound serious, not cinematic.
Cat's Claw contains two pharmacologically distinct alkaloid classes: Pentacyclic Oxindole Alkaloids (POA, mitraphylline, isomitraphylline, pteropodine, isopteropodine, speciophylline, uncarine F) which are IMMUNOSTIMULATORY and therapeutically desired, and Tetracyclic Oxindole Alkaloids (TOA, rhynchophylline, isorhynchophylline) which have DIFFERENT and potentially ANTAGONISTIC effects, counteracting POA immunostimulatory activity. Additional compounds include quinovic acid glycosides (anti-inflammatory, antiviral), proanthocyanidins (antioxidant), catechins, triterpenes (ursolic acid, oleanolic acid), and beta-sitosterol. THE POA/TOA DISTINCTION IS CRITICAL: plant chemotype, harvesting season, geographic location, and time of day affect the ratio. TOA-dominant preparations may be therapeutically inert or counterproductive. The PRIMARY mechanism involves POA immunomodulation, enhancing B and T lymphocyte proliferation, increasing phagocytic activity, and modulating cytokine production. This is IMMUNOMODULATORY, not simply immunostimulatory, POA can upregulate suppressed immunity AND calm overactive immunity. Both POA and quinovic acid glycosides inhibit NF-kB activation, reducing TNF-alpha, IL-1beta, and IL-6. POA (specifically isopteropodine) enhances DNA repair mechanisms, potentially protecting against mutagenesis. TOA ANTAGONISM is the key quality concern: a preparation with high TOA/POA ratio will have reduced immune benefit.
Cat's claw is usually reached for when inflammation, immune complexity, or long-view tissue stress need a stronger jungle-vine corrective. It belongs first to the bark-and-vine support lane.
Route panel
Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.
Preparations
A simmered inner-bark tea delivering pentacyclic oxindole alkaloids (POA) for immune modulation and anti-inflammatory support
25 min simmer
Contraindicated in pregnancy and lactation (traditional Amazonian contraceptive/abortifacient use). May counteract immunosuppressive therapy -- coordinate with prescriber. Some alkaloids inhibit CYP3A4, potentially affecting statins, calcium channel blockers, and antiretrovirals. Discontinue 2 weeks before surgery (antiplatelet effects). Species and chemotype verification is critical.
An alcohol extraction of Uncaria tomentosa bark for joint inflammation and immune-complex conditions
6-8 weeks extraction
Despite immunomodulatory (not just stimulatory) action, coordinate use with prescriber if on immunosuppressive therapy. Contraindicated in pregnancy/lactation. Discontinue 2 weeks before surgery. CYP3A4 inhibition means potential interactions with many pharmaceutical drugs.
Comparison
Cat's claw is often compared with astragalus or olive leaf in immune language, but it is woodier, more forceful, and less everyday than either.
Choose cat's claw when the picture calls for a stronger immune-modulating botanical. Do not write it as if it were a casual tonic tea.
Quality
Fresh bark or vine material should be correctly identified and clean, not moldy or anonymous.
Dried cat's claw should remain bark-rich and traceable to species. Quality here starts with identification.
Cat's claw is not an oil herb. Keep the route in bark and extract logic.
This is more a sourcing and species-integrity conversation than a casual home garden one.
Companion
With hematite, cat's claw reads as slow durable support under inflammatory load.
Moss Agate is the primary crystal companion for Cat's Claw, connecting through rainforest energy, growth through dense challenge, with the "gardener's stone" mirroring Cat's Claw's vine reaching over 100 feet through the densest forest canopy toward light. Cat's Claw is THE VINE THAT REACHES, it penetrates, transforms, and modulates with persistent immunomodulatory action that can both upregulate suppressed immunity and calm overactive immunity, demonstrated clinically in rheumatoid arthritis. Green Tourmaline brings deep vitality, immune support, and heart-centered strength with penetrating healing energy matching Cat's Claw's deep tissue action. Bloodstone provides immune activation, blood purification, and courage, the warrior-healer stone for the warrior-healer vine honored by the Ashaninka people of the Peruvian Amazon. Malachite embodies transformation and deep healing, with its banded growth pattern mirroring the vine's relentless growth toward light. Green and red stones honor the vine's journey from dark forest floor (immune depth) to canopy light (vitality).
Crystal side
The deeper layer
Clinical and compound notes are included as a research layer, not as treatment instructions.
Cat's Claw presents a COMPLEX autoimmune picture: it is immunoMODULATORY rather than simply stimulatory, and clinical evidence shows benefit in rheumatoid arthritis (an autoimmune condition). General precaution suggests monitoring when used with autoimmune diseases. May counteract immunosuppressive therapy, coordinate with prescriber. May inhibit platelet aggregation with theoretical bleeding risk alongside warfarin and aspirin. Some alkaloids (particularly TOA, rhynchophylline) have hypotensive effects that may potentiate blood pressure medications. CONTRAINDICATED in pregnancy and lactation due to traditional Amazonian use as contraceptive and potential abortifacient properties. Some alkaloids inhibit CYP3A4, potentially affecting metabolism of statins, calcium channel blockers, and antiretrovirals. Discontinue 2 weeks before surgery. QUALITY CONTROL is critical: POA vs TOA chemotype determines therapeutic value. TOA-dominant preparations may be ineffective or counterproductive for immune support. Look for "POA-standardized" or "TOA-free" extracts. Species confusion also exists: Uncaria tomentosa differs from U. guianensis and the TCM herb U. rhynchophylla (Gou Teng).
Lore & history
Cultural notes are presented as tradition and historical context, attributed to where they come from.
The Ashaninka people of the Peruvian Amazon considered cat's claw (una de gato) a powerful healing plant. They used inner bark decoctions for arthritis, gastric ulcers, and infections, and it held spiritual significance in their shamanic healing tradition.
The Ashaninka people of the Peruvian central Amazon are considered the primary indigenous custodians of cat's claw (Uncaria tomentosa) knowledge. They use the inner bark decoction for arthritis, gastric ulcers, tumors, and as a general immune tonic. Ashaninka healers distinguish between two types of cat's claw based on the color of the inner bark and prescribe them differently. The curved thorns resembling cat claws, which give the vine its name, are used by the plant to climb through the canopy. Ashaninka ethnobotanical knowledge of this plant was the starting point for all subsequent Western research.
The Aguaruna (Awajun) people of northern Peru use cat's claw for treating inflammation, bone pain, and urinary tract infections. Aguaruna women traditionally prepare the bark decoction for post-partum recovery and to treat deep internal inflammation. The Aguaruna practice of long-simmering the bark for several hours to produce a concentrated decoction was noted by ethnobotanist Walter Lewis in his studies of Amazonian pharmacopoeias. This method produces a preparation with significantly higher alkaloid concentration than brief infusions, reflecting sophisticated empirical pharmacology.
Shipibo-Conibo healers in the Ucayali River basin used cat's claw bark for inflammatory conditions, digestive disorders, and as a general immune tonic. The vine was harvested sustainably and prepared as a long-simmered decoction.
The Aguaruna (Awajun) people of northern Peru used cat's claw preparations as a female contraceptive and postpartum tonic. Women consumed bark decoctions to space births and to recover strength after childbirth.
Cat's claw entered mestizo (mixed-heritage) herbalism in Amazonian market towns like Iquitos, Pucallpa, and Tingo Maria during the 20th century, where it is sold in every herbal market as a general tonic and anti-inflammatory. Curanderos (traditional healers) prescribe it for gastritis, arthritis, and as a blood purifier. The dried bark is sold in large bags and brewed as a daily health tea. This mestizo tradition represents the bridge between deep indigenous Ashaninka knowledge and the global herbal market that would explode in the 1990s after Austrian researcher Klaus Keplinger's work brought cat's claw to international attention.
Austrian naturalist and researcher Klaus Keplinger first encountered cat's claw among the Ashaninka in the 1970s and spent decades studying its alkaloid chemistry. He identified pentacyclic oxindole alkaloids (POAs) as the primary immunomodulatory compounds and secured several patents. Keplinger's research, published from the 1980s onward, triggered an international demand for cat's claw that transformed the economies of remote Amazonian communities. His work established the scientific foundation for cat's claw as an immunostimulant and anti-inflammatory, leading to its adoption in European and North American natural medicine.
Cat's claw became a widely sold remedy in Peruvian herbal markets (mercados de hierbas) during the 20th century, bridging Indigenous knowledge and urban folk medicine. Vendors in Iquitos and Lima sold dried bark for cancer, arthritis, and immune support.
Austrian researcher Klaus Keplinger documented cat's claw use among Amazonian peoples in the 1970s and conducted early pharmacological analyses of its alkaloids. His research brought Uncaria tomentosa to international attention, leading to its adoption in European and North American herbal practice.
The Peruvian government officially recognized cat's claw as a medicinal plant of national importance in 1995, reflecting both its indigenous heritage and its growing global commercial value. Peru implemented harvesting regulations to prevent overexploitation of wild Uncaria tomentosa populations. The national recognition also prompted cultivation programs to supplement wild harvest. Cat's claw became Peru's second-largest botanical export (after maca), generating significant income for Amazonian communities. This governmental recognition represents a rare case of a nation formally protecting an indigenous medicinal plant tradition while managing its commercial development.
Questions
Cat's claw presents a complex autoimmune picture: it is immunomodulatory rather than simply stimulatory, with clinical evidence showing benefit in rheumatoid arthritis. However, it may counteract immunosuppressive therapy and should be coordinated with a prescriber. It has theoretical bleeding risk through platelet aggregation inhibition. Some alkaloid chemotypes (tetracyclic oxindole alkaloids) actually antagonize the immunostimulatory pentacyclic alkaloids, making chemotype selection critical.
Inner bark decoction (2-5g simmered 15-20 minutes) or standardized extract (300-500mg, 1-3 times daily) are standard preparations. The critical pharmacological distinction is between pentacyclic oxindole alkaloids (POA: mitraphylline, isomitraphylline, pteropodine, isopteropodine) which are immunostimulatory and therapeutically desired, versus tetracyclic oxindole alkaloids (TOA) which antagonize POA effects. Quality products should be standardized to POA content with minimal TOA.
Fresh bark or vine material should be correctly identified and clean, not moldy or anonymous. Dried cat's claw should remain bark-rich and traceable to Uncaria tomentosa specifically. Quality starts with species identification, as U. guianensis (a related species) has a different alkaloid profile. Products should specify POA (pentacyclic oxindole alkaloid) content and ideally confirm low TOA levels, since the tetracyclic forms antagonize the desired immune-modulating activity.
Uncaria tomentosa (Rubiaceae) is the primary medicinal species with the most clinical research, containing both pentacyclic and tetracyclic oxindole alkaloids. U. guianensis is a related species with a different alkaloid ratio and less clinical evidence. Neither should be confused with Uncaria rhynchophylla (gou teng, used in TCM) which has different isorhynchophylline-type alkaloids. Several unrelated plants bear the common name cat's claw in regional herbalism, making Latin binomial identification essential.
Dried inner bark retains oxindole alkaloid content for 2-3 years when stored in airtight containers away from moisture and light. The alkaloids are relatively stable in dried bark form. Tinctures (1:5 in 40-50% alcohol) maintain potency for 3-5 years. Cat's claw is not an oil herb; bark decoction and standardized extract are its legitimate preparation routes. Decoctions should be prepared fresh and consumed within 24-48 hours as aqueous preparations lack preservative stability.
Sources & Citations
Peer-reviewed sources for the pharmacological and clinical claims on this page. Crystalis herb entries describe tradition and current research; they are reference, not medical advice.
SCI
Resource framing
Crystalis is a reference resource for herbal, crystal, and somatic practice.
This library is designed to help readers orient, compare, and research. It is not a substitute for medical care or practitioner judgment.
Clinical and compound notes are included as a research layer, not as treatment instructions.
Evidence and safety may differ by preparation. Essential oil, tea, tincture, extract, infused oil, and topical use are not interchangeable.